Gut microbial short-chain fatty acids and the risk of diabetes

A new study used genome-wide association data and Mendelian randomization to investigate associations between the gut microbiome and metabolic traits. The researchers demonstrate that host genetic variants influence levels of the short-chain fatty acids butyrate and propionate in the gut, which in turn modulate host glycaemic metabolism.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Host genetics, gut microbiota SCFAs and risk of diabetes.


  1. 1.

    Lau, W. L. et al. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. Clin. Sci. 132, 509–522 (2018).

  2. 2.

    Canfora, E. E. et al. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat. Rev. Endocrinol. https://doi.org/10.1038/s41574-019-0156-z (2019).

  3. 3.

    Sanna, S. et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat. Genet. https://doi.org/10.1038/s41588-019-0350-x (2019).

  4. 4.

    Vatanen, T. et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562, 589–594 (2018).

  5. 5.

    de Goffau, M. C. et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 62, 1238–1244 (2013).

  6. 6.

    Zhao, L. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359, 1151–1156 (2018).

  7. 7.

    Evans, D. M. & Davey Smith, G. Mendelian randomization: new applications in the coming age of hypothesis-free causality. Annu. Rev. Genomics Hum. Genet. 16, 327–350 (2015).

  8. 8.

    Wong, J. et al. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am. J. Nephrol. 39, 230–237 (2014).

Download references


W.L.L. is funded by American Heart Association grant 17IRG33410803 and National Institutes of Health–National Institute of Neurological Disorders and Stroke grant R01 NS20989.

Author information

Correspondence to Wei Ling Lau or Nosratola D. Vaziri.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark